Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Sex Transm Infect ; 77(5): 353-7, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11588282

ABSTRACT

OBJECTIVES: To examine changes in the incidence and prevalence of herpes simplex type 2 (HSV-2) infection in a birth cohort of 26 year old New Zealanders in whom seroprevalence had been measured at 3.4% at age 21. METHODS: Sera from 869 cohort members were tested using an indirect IgG enzyme linked immunoassay specific to the HSV-2 glycoprotein G. Serological results were compared with detailed sexual histories. RESULTS: In all, 96 participants (11%) were seropositive for HSV-2, including at least 56 who seroconverted after their 21st birthday. Among those known to be seronegative at age 21, the annual seroconversion rate was 13.5 cases per 1000 per year, compared with 8.1 cases per 1000 per sexually active year before age 21. New infections were associated with female sex and an early age of first intercourse. The average rate of partner change was lower in the cohort after age 21, and was only modestly increased among those who acquired new HSV-2 infections between ages 21 and 26. CONCLUSIONS: HSV-2 seroprevalence has risen sharply in this sexually active cohort, despite a reduction in the overall level of partner change. Increased rates of HSV-2 acquisition after age 21 may be due to a higher prevalence of infection in the pool of potential partners encountered during the third decade of life. Factors related to partner choice may have more influence on the risk of HSV-2 infection than the number of sexual partners alone.


Subject(s)
Herpes Genitalis/epidemiology , Herpesvirus 2, Human/immunology , Adult , Age Factors , Antibodies, Viral/blood , Cohort Studies , Female , Herpes Genitalis/immunology , Humans , Incidence , Male , New Zealand/epidemiology , Prevalence , Risk Factors , Seroepidemiologic Studies , Sex Factors
2.
JAMA ; 272(15): 1203-5, 1994 Oct 19.
Article in English | MEDLINE | ID: mdl-7933349

ABSTRACT

OBJECTIVE: To assess cholera recognition and treatment by US health care workers in the largest cholera outbreak in the United States this century. DESIGN: We reviewed the medical records of passengers from a flight on which a cholera outbreak occurred. To determine the availability of oral rehydration solutions, we surveyed treatment facilities and referral pharmacies. SETTING: On February 14, 1992, more than 100 passengers on a flight from South America to Los Angeles, Calif, were infected with toxigenic Vibrio cholerae O1. SUBJECTS: Fifty-four of 67 passengers who sought care in California and Nevada. RESULTS: We reviewed the records of 54 passengers, including 39 with diarrhea and 15 without symptoms. All 17 persons who sought treatment before the outbreak was widely reported by the media had diarrhea. For 12 of these persons, recent travel to South America was noted, but only those four whose records listed cholera as a possible diagnosis were immediately hospitalized. Seven sought care again within 3 days; three were dehydrated, two of these three were hospitalized, and one of these two died. None of the 26 patients suspected to have cholera received appropriate fluids; severely dehydrated patients did not receive Ringer's lactate solution and those not severely dehydrated did not receive an oral rehydration solution. None of the facilities and pharmacies involved stocked World Health Organization oral rehydration salts solution, the preferred solution for treating cholera and other diarrheal diseases. CONCLUSIONS: Treatment of cholera in the United States was suboptimal. Oral fluids appropriate for the treatment of cholera and other diarrheal diseases were generally unavailable. Widespread cholera in the developing world means that US physicians should be prepared to treat "imported" cases. Physicians evaluating patients with diarrhea should obtain a travel history, should consider cholera in patients returning from countries with endemic or epidemic cholera, and should instruct patients in appropriate use of World Health Organization oral rehydration salts solution or other oral rehydration solutions containing 75 to 90 mmol/L of sodium. Pharmacies and medical facilities should stock these solutions.


Subject(s)
Cholera/diagnosis , Cholera/therapy , Cholera/epidemiology , Disease Outbreaks/prevention & control , Fluid Therapy/statistics & numerical data , Humans , Rehydration Solutions/supply & distribution , Travel , United States/epidemiology
3.
Disasters ; 18(2): 160-70, 1994 Jun.
Article in English | MEDLINE | ID: mdl-8076160

ABSTRACT

Mortality patterns from earthquakes in the United States may differ from those observed in other parts of the world. We reviewed coroner and medical examiner records for all investigated deaths from seven California counties for 15 days following the Loma Prieta earthquake of October 17, 1989 (N = 327). Data on the circumstances surrounding death were used to classify each case as directly earthquake-related, indirectly earthquake-related, or not earthquake-related. Fifty-seven deaths were judged as directly earthquake-related. Six other deaths were indirectly related. Ten circumstances accounted for all directly earthquake-related deaths, with the collapse of an elevated freeway accounting for 40 of these deaths. Forty-six (80.8 per cent) of the 57 directly earthquake-related deaths occurred in motor vehicles on public roadways. Fifty-three (93.0 per cent) of the directly earthquake-related deaths occurred within seconds or minutes of injury. Future earthquake deaths in the United States may best be prevented by identifying and modifying seismic hazards in earthquake-prone regions, particularly transportation structures.


Subject(s)
Coroners and Medical Examiners , Death Certificates , Disasters , Population Surveillance/methods , Adolescent , Adult , Aged , Aged, 80 and over , California/epidemiology , Cause of Death , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Middle Aged , Reproducibility of Results
4.
Obstet Gynecol ; 82(5): 797-801, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8414327

ABSTRACT

OBJECTIVE: To describe the effects of measles in pregnancy using a large case series. METHODS: Pregnant women with measles were identified by county health department records, and their hospital and clinic records were reviewed. When available, records for the infants of case patients were also reviewed. RESULTS: Fifty-eight pregnant women with measles were identified. Thirty-five (60%) were hospitalized for measles, 15 (26%) were diagnosed with pneumonia, and two (3%) died of measles complications. Excluding three induced abortions, 18 pregnancies (31%) ended prematurely; five were spontaneous abortions and 13 were preterm deliveries. All but two of the 18 pregnancies that terminated early did so within 14 days of rash onset. Two term infants were born with minor congenital anomalies, but their mothers had measles late in the third trimester. No newborns were diagnosed with congenital measles. CONCLUSIONS: The incidence of death and other complications from measles during pregnancy may be higher than expected for age-comparable, nonpregnant women. Measles in pregnancy may lead to high rates of fetal loss and prematurity, especially in the first 2 weeks after the onset of rash.


Subject(s)
Abortion, Spontaneous/epidemiology , Congenital Abnormalities/epidemiology , Fetal Death/epidemiology , Measles , Obstetric Labor, Premature/epidemiology , Pregnancy Complications, Infectious , Abortion, Spontaneous/etiology , Adolescent , Adult , Congenital Abnormalities/etiology , Female , Fetal Death/etiology , Hospitalization , Humans , Infant, Newborn , Obstetric Labor, Premature/etiology , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...